{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T17:02:45Z","timestamp":1790787765181,"version":"4.1.0"},"reference-count":123,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,10,22]]},"DOI":"10.7759\/cureus.72106","type":"journal-article","created":{"date-parts":[[2024,10,22]],"date-time":"2024-10-22T11:31:43Z","timestamp":1729596703000},"source":"Crossref","is-referenced-by-count":6,"title":["Cardiac Failure and Cardiogenic Shock: Insights Into Pathophysiology, Classification, and Hemodynamic Assessment"],"prefix":"10.7759","author":[{"given":"Stavroula  A","family":"Siopi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Polychronis","family":"Antonitsis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios T","family":"Karapanagiotidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios","family":"Tagarakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christos","family":"Voucharas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyriakos","family":"Anastasiadis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh TA","year":"2021","unstructured":"McDonagh TA, Metra M, Adamo M, et al.. 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021, 42:3599-726. 10.1093\/eurheartj\/ehab368","journal-title":"Eur Heart J"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1038\/nrcardio.2016.25","article-title":"Epidemiology and aetiology of heart failure","volume":"13","author":"Ziaeian B","year":"2016","unstructured":"Ziaeian B, Fonarow GC. Epidemiology and aetiology of heart failure. Nat Rev Cardiol. 2016, 13:368-78. 10.1038\/nrcardio.2016.25","journal-title":"Nat Rev Cardiol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.carpath.2011.11.007","article-title":"The pathophysiology of heart failure","volume":"21","author":"Kemp CD","year":"2012","unstructured":"Kemp CD, Conte JV. The pathophysiology of heart failure. Cardiovasc Pathol. 2012, 21:365-71. 10.1016\/j.carpath.2011.11.007","journal-title":"Cardiovasc Pathol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.rec.2022.05.005","article-title":"2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) with the special contribution of the Heart Failure Association (HFA) of the ESC","volume":"75","author":"McDonagh TA","year":"2022","unstructured":"McDonagh TA, Metra M, Adamo M, et al.. 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) with the special contribution of the Heart Failure Association (HFA) of the ESC. Rev Esp Cardiol (Engl Ed). 2022, 75:523. 10.1016\/j.rec.2022.05.005","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000525","article-title":"Contemporary management of cardiogenic shock: a scientific statement from the American Heart Association","volume":"136","author":"van Diepen S","year":"2017","unstructured":"van Diepen S, Katz JN, Albert NM, et al.. Contemporary management of cardiogenic shock: a scientific statement from the American Heart Association. Circulation. 2017, 136:e232-68. 10.1161\/CIR.0000000000000525","journal-title":"Circulation"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-020-0151-7","article-title":"Acute heart failure","volume":"6","author":"Arrigo M","year":"2020","unstructured":"Arrigo M, Jessup M, Mullens W, Reza N, Shah AM, Sliwa K, Mebazaa A. Acute heart failure. Nat Rev Dis Primers. 2020, 6:16. 10.1038\/s41572-020-0151-7","journal-title":"Nat Rev Dis Primers"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2021-320131","article-title":"Prevalence, incidence and survival of heart failure: a systematic review","volume":"108","author":"Emmons-Bell S","year":"2022","unstructured":"Emmons-Bell S, Johnson C, Roth G. Prevalence, incidence and survival of heart failure: a systematic review. Heart. 2022, 108:1351-60. 10.1136\/heartjnl-2021-320131","journal-title":"Heart"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2021.04.070","article-title":"Classification of heart\u00a0failure according to ejection fraction: JACC review topic of the week","volume":"77","author":"Lam CS","year":"2021","unstructured":"Lam CS, Solomon SD. Classification of heart\u00a0failure according to ejection fraction: JACC review topic of the week. J Am Coll Cardiol. 2021, 77:3217-25. 10.1016\/j.jacc.2021.04.070","journal-title":"J Am Coll Cardiol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1038\/nrcardio.2010.165","article-title":"Epidemiology and risk profile of heart failure","volume":"8","author":"Bui AL","year":"2011","unstructured":"Bui AL, Horwich TB, Fonarow GC. Epidemiology and risk profile of heart failure. Nat Rev Cardiol. 2011, 8:30-41. 10.1038\/nrcardio.2010.165","journal-title":"Nat Rev Cardiol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1023\/a:1007383914444","article-title":"Classification of heart failure in population based research: an assessment of six heart failure scores","volume":"13","author":"Mosterd A","year":"1997","unstructured":"Mosterd A, Deckers JW, Hoes AW, Nederpel A, Smeets A, Linker DT, Grobbee DE. Classification of heart failure in population based research: an assessment of six heart failure scores. Eur J Epidemiol. 1997, 13:491-502. 10.1023\/a:1007383914444","journal-title":"Eur J Epidemiol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.rec.2018.01.003","article-title":"Vasoactive inotropic score as a predictor of mortality in adult patients with cardiogenic shock: medical therapy versus ECMO","volume":"72","author":"Na SJ","year":"2019","unstructured":"Na SJ, Chung CR, Cho YH, et al.. Vasoactive inotropic score as a predictor of mortality in adult patients with cardiogenic shock: medical therapy versus ECMO. Rev Esp Cardiol (Engl Ed). 2019, 72:40-7. 10.1016\/j.rec.2018.01.003","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.rec.2014.11.004","article-title":"Acute heart failure: epidemiology, risk factors, and prevention","volume":"68","author":"Farmakis D","year":"2015","unstructured":"Farmakis D, Parissis J, Lekakis J, Filippatos G. Acute heart failure: epidemiology, risk factors, and prevention. Rev Esp Cardiol (Engl Ed). 2015, 68:245-8. 10.1016\/j.rec.2014.11.004","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchf.2017.08.011","article-title":"Refining classification of heart failure based on ejection fraction","volume":"5","author":"Fonarow GC","year":"2017","unstructured":"Fonarow GC. Refining classification of heart failure based on ejection fraction. JACC Heart Fail. 2017, 5:808-9. 10.1016\/j.jchf.2017.08.011","journal-title":"JACC Heart Fail"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehl193","article-title":"EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population","volume":"27","author":"Nieminen MS","year":"2006","unstructured":"Nieminen MS, Brutsaert D, Dickstein K, et al.. EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population. Eur Heart J. 2006, 27:2725-36. 10.1093\/eurheartj\/ehl193","journal-title":"Eur Heart J"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2016.10.042","article-title":"The heart failure pandemic: the clinical and economic burden in Greece","volume":"227","author":"Stafylas P","year":"2017","unstructured":"Stafylas P, Farmakis D, Kourlaba G, Giamouzis G, Tsarouhas K, Maniadakis N, Parissis J. The heart failure pandemic: the clinical and economic burden in Greece. Int J Cardiol. 2017, 227:923-9. 10.1016\/j.ijcard.2016.10.042","journal-title":"Int J Cardiol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2013.12.028","article-title":"The annual global economic burden of heart failure","volume":"171","author":"Cook C","year":"2014","unstructured":"Cook C, Cole G, Asaria P, Jabbour R, Francis DP. The annual global economic burden of heart failure. Int J Cardiol. 2014, 171:368-76. 10.1016\/j.ijcard.2013.12.028","journal-title":"Int J Cardiol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvac013","article-title":"Global burden of heart failure: a comprehensive and updated review of epidemiology","volume":"118","author":"Savarese G","year":"2023","unstructured":"Savarese G, Becher PM, Lund LH, Seferovic P, Rosano GM, Coats AJ. Global burden of heart failure: a comprehensive and updated review of epidemiology. Cardiovasc Res. 2023, 118:3272-87. 10.1093\/cvr\/cvac013","journal-title":"Cardiovasc Res"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1186\/s12872-018-0815-3","article-title":"Cost-of-illness studies in heart failure: a systematic review 2004-2016","volume":"18","author":"Lesyuk W","year":"2018","unstructured":"Lesyuk W, Kriza C, Kolominsky-Rabas P. Cost-of-illness studies in heart failure: a systematic review 2004-2016. BMC Cardiovasc Disord. 2018, 18:74. 10.1186\/s12872-018-0815-3","journal-title":"BMC Cardiovasc Disord"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2015-307461","article-title":"The pathophysiology of hypertensive acute heart failure","volume":"101","author":"Viau DM","year":"2015","unstructured":"Viau DM, Sala-Mercado JA, Spranger MD, O'Leary DS, Levy PD. The pathophysiology of hypertensive acute heart failure. Heart. 2015, 101:1861-7. 10.1136\/heartjnl-2015-307461","journal-title":"Heart"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2018.12.076","article-title":"Anatomy, function, and dysfunction of\u00a0the right\u00a0ventricle: JACC state-of-the-art review","volume":"73","author":"Sanz J","year":"2019","unstructured":"Sanz J, S\u00e1nchez-Quintana D, Bossone E, Bogaard HJ, Naeije R. Anatomy, function, and dysfunction of\u00a0the right\u00a0ventricle: JACC state-of-the-art review. J Am Coll Cardiol. 2019, 73:1463-82. 10.1016\/j.jacc.2018.12.076","journal-title":"J Am Coll Cardiol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.hfc.2018.02.001","article-title":"The right heart-pulmonary circulation unit: physiopathology","volume":"14","author":"Naeije R","year":"2018","unstructured":"Naeije R, Vanderpool R, Peacock A, Badagliacca R. The right heart-pulmonary circulation unit: physiopathology. Heart Fail Clin. 2018, 14:237-45. 10.1016\/j.hfc.2018.02.001","journal-title":"Heart Fail Clin"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.106.632208","article-title":"Right ventricular function and failure: report of a National Heart, Lung, and Blood Institute working group on cellular and molecular mechanisms of right heart failure","volume":"114","author":"Voelkel NF","year":"2006","unstructured":"Voelkel NF, Quaife RA, Leinwand LA, et al.. Right ventricular function and failure: report of a National Heart, Lung, and Blood Institute working group on cellular and molecular mechanisms of right heart failure. Circulation. 2006, 114:1883-91. 10.1161\/CIRCULATIONAHA.106.632208","journal-title":"Circulation"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.107.653584","article-title":"Right ventricular function in cardiovascular disease, part II: pathophysiology, clinical importance, and management of right ventricular failure","volume":"117","author":"Haddad F","year":"2008","unstructured":"Haddad F, Doyle R, Murphy DJ, Hunt SA. Right ventricular function in cardiovascular disease, part II: pathophysiology, clinical importance, and management of right ventricular failure. Circulation. 2008, 117:1717-31. 10.1161\/CIRCULATIONAHA.107.653584","journal-title":"Circulation"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.113.001375","article-title":"Right versus left ventricular failure: differences, similarities, and interactions","volume":"129","author":"Friedberg MK","year":"2014","unstructured":"Friedberg MK, Redington AN. Right versus left ventricular failure: differences, similarities, and interactions. Circulation. 2014, 129:1033-44. 10.1161\/CIRCULATIONAHA.113.001375","journal-title":"Circulation"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.113.000271","article-title":"Bridge-to-decision therapy with a continuous-flow external ventricular assist device in refractory cardiogenic shock of various causes","volume":"7","author":"Takayama H","year":"2014","unstructured":"Takayama H, Soni L, Kalesan B, et al.. Bridge-to-decision therapy with a continuous-flow external ventricular assist device in refractory cardiogenic shock of various causes. Circ Heart Fail. 2014, 7:799-806. 10.1161\/CIRCHEARTFAILURE.113.000271","journal-title":"Circ Heart Fail"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1097\/HCO.0b013e3283511e60","article-title":"Right heart failure after left ventricular assist device implantation: early and late","volume":"27","author":"MacGowan GA","year":"2012","unstructured":"MacGowan GA, Schueler S. Right heart failure after left ventricular assist device implantation: early and late. Curr Opin Cardiol. 2012, 27:296-300. 10.1097\/HCO.0b013e3283511e60","journal-title":"Curr Opin Cardiol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtcvs.2009.11.020","article-title":"Right ventricular failure in patients with the HeartMate II continuous-flow left ventricular assist device: incidence, risk factors, and effect on outcomes","volume":"139","author":"Kormos RL","year":"2010","unstructured":"Kormos RL, Teuteberg JJ, Pagani FD, et al.. Right ventricular failure in patients with the HeartMate II continuous-flow left ventricular assist device: incidence, risk factors, and effect on outcomes. J Thorac Cardiovasc Surg. 2010, 139:1316-24. 10.1016\/j.jtcvs.2009.11.020","journal-title":"J Thorac Cardiovasc Surg"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.14797\/mdcj-11-1-18","article-title":"Predictors and management of right heart failure after left ventricular assist device implantation","volume":"11","author":"Fida N","year":"2015","unstructured":"Fida N, Loebe M, Estep JD, Guha A. Predictors and management of right heart failure after left ventricular assist device implantation. Methodist Debakey Cardiovasc J. 2015, 11:18-23. 10.14797\/mdcj-11-1-18","journal-title":"Methodist Debakey Cardiovasc J"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2015.06.103","article-title":"Left ventricular vs. biventricular mechanical support: decision making and strategies for avoidance of right heart failure after left ventricular assist device implantation","volume":"198","author":"Dandel M","year":"2015","unstructured":"Dandel M, Krabatsch T, Falk V. Left ventricular vs. biventricular mechanical support: decision making and strategies for avoidance of right heart failure after left ventricular assist device implantation. Int J Cardiol. 2015, 198:241-50. 10.1016\/j.ijcard.2015.06.103","journal-title":"Int J Cardiol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2009.11.026","article-title":"Risk factors predictive of right ventricular failure after left ventricular assist device implantation","volume":"105","author":"Drakos SG","year":"2010","unstructured":"Drakos SG, Janicki L, Horne BD, et al.. Risk factors predictive of right ventricular failure after left ventricular assist device implantation. Am J Cardiol. 2010, 105:1030-5. 10.1016\/j.amjcard.2009.11.026","journal-title":"Am J Cardiol"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1111\/aor.12518","article-title":"Systematic review of phosphodiesterase-5 inhibitor use in right ventricular failure following left ventricular assist device implantation","volume":"40","author":"Baker WL","year":"2016","unstructured":"Baker WL, Radojevic J, Gluck JA. Systematic review of phosphodiesterase-5 inhibitor use in right ventricular failure following left ventricular assist device implantation. Artif Organs. 2016, 40:123-8. 10.1111\/aor.12518","journal-title":"Artif Organs"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01900-2018","article-title":"Pathophysiology of the right ventricle and\u00a0of the pulmonary circulation in pulmonary hypertension: an update","volume":"53","author":"Vonk Noordegraaf A","year":"2019","unstructured":"Vonk Noordegraaf A, Chin KM, Haddad F, et al.. Pathophysiology of the right ventricle and\u00a0of the pulmonary circulation in pulmonary hypertension: an update. Eur Respir J. 2019, 53:1801900. 10.1183\/13993003.01900-2018","journal-title":"Eur Respir J"},{"key":"ref33","article-title":"Right ventricular failure: physiology and assessment","volume":"71","author":"Guarracino F","year":"2005","unstructured":"Guarracino F, Cariello C, Danella A, et al.. Right ventricular failure: physiology and assessment. Minerva Anestesiol. 2005, 71:307-12.","journal-title":"Minerva Anestesiol"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.107.653576","article-title":"Right ventricular function in cardiovascular disease, part I: anatomy, physiology, aging, and functional assessment of the right ventricle","volume":"117","author":"Haddad F","year":"2008","unstructured":"Haddad F, Hunt SA, Rosenthal DN, Murphy DJ. Right ventricular function in cardiovascular disease, part I: anatomy, physiology, aging, and functional assessment of the right ventricle. Circulation. 2008, 117:1436-48. 10.1161\/CIRCULATIONAHA.107.653576","journal-title":"Circulation"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.15420\/cfr.2019.15.2","article-title":"Right ventricular failure: pathophysiology, diagnosis and treatment","volume":"5","author":"Arrigo M","year":"2019","unstructured":"Arrigo M, Huber LC, Winnik S, et al.. Right ventricular failure: pathophysiology, diagnosis and treatment. Card Fail Rev. 2019, 5:140-6. 10.15420\/cfr.2019.15.2","journal-title":"Card Fail Rev"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccl.2020.01.009","article-title":"Pathophysiology of acute and chronic right heart failure","volume":"38","author":"Thandavarayan RA","year":"2020","unstructured":"Thandavarayan RA, Chitturi KR, Guha A. Pathophysiology of acute and chronic right heart failure. Cardiol Clin. 2020, 38:149-60. 10.1016\/j.ccl.2020.01.009","journal-title":"Cardiol Clin"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1093\/ejechocard\/jen308","article-title":"Duration of right ventricular contraction predicts the efficacy of bosentan treatment in patients with pulmonary hypertension","volume":"10","author":"Duffels MG","year":"2009","unstructured":"Duffels MG, Hardziyenka M, Surie S, et al.. Duration of right ventricular contraction predicts the efficacy of bosentan treatment in patients with pulmonary hypertension. Eur J Echocardiogr. 2009, 10:433-8. 10.1093\/ejechocard\/jen308","journal-title":"Eur J Echocardiogr"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2007.01.028","article-title":"Abnormal left ventricular diastolic filling in chronic thromboembolic pulmonary hypertension: true diastolic dysfunction or left ventricular underfilling?","volume":"49","author":"Gurudevan SV","year":"2007","unstructured":"Gurudevan SV, Malouf PJ, Auger WR, et al.. Abnormal left ventricular diastolic filling in chronic thromboembolic pulmonary hypertension: true diastolic dysfunction or left ventricular underfilling?. J Am Coll Cardiol. 2007, 49:1334-9. 10.1016\/j.jacc.2007.01.028","journal-title":"J Am Coll Cardiol"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.01031.2005","article-title":"Impaired left ventricular filling due to right-to-left ventricular interaction in patients with pulmonary arterial hypertension","volume":"290","author":"Gan C","year":"2006","unstructured":"Gan C, Lankhaar JW, Marcus JT, et al.. Impaired left ventricular filling due to right-to-left ventricular interaction in patients with pulmonary arterial hypertension. Am J Physiol Heart Circ Physiol. 2006, 290:H1528-33. 10.1152\/ajpheart.01031.2005","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1378\/chest.119.6.1761","article-title":"Impaired left ventricular filling due to right ventricular pressure overload in primary pulmonary hypertension: noninvasive monitoring using MRI","volume":"119","author":"Marcus JT","year":"2001","unstructured":"Marcus JT, Vonk Noordegraaf A, Roeleveld RJ, Postmus PE, Heethaar RM, Van Rossum AC, Boonstra A. Impaired left ventricular filling due to right ventricular pressure overload in primary pulmonary hypertension: noninvasive monitoring using MRI. Chest. 2001, 119:1761-5. 10.1378\/chest.119.6.1761","journal-title":"Chest"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1016\/j.echo.2008.05.005","article-title":"Evaluation of right intraventricular dyssynchrony by two-dimensional strain echocardiography in patients with pulmonary arterial hypertension","volume":"21","author":"Kalogeropoulos AP","year":"2008","unstructured":"Kalogeropoulos AP, Georgiopoulou VV, Howell S, Pernetz MA, Fisher MR, Lerakis S, Martin RP. Evaluation of right intraventricular dyssynchrony by two-dimensional strain echocardiography in patients with pulmonary arterial hypertension. J Am Soc Echocardiogr. 2008, 21:1028-34. 10.1016\/j.echo.2008.05.005","journal-title":"J Am Soc Echocardiogr"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2007.10.041","article-title":"Interventricular mechanical asynchrony in pulmonary arterial hypertension: left-to-right delay in peak shortening is related to right ventricular overload and left ventricular underfilling","volume":"51","author":"Marcus JT","year":"2008","unstructured":"Marcus JT, Gan CT, Zwanenburg JJ, Boonstra A, Allaart CP, G\u00f6tte MJ, Vonk-Noordegraaf A. Interventricular mechanical asynchrony in pulmonary arterial hypertension: left-to-right delay in peak shortening is related to right ventricular overload and left ventricular underfilling. J Am Coll Cardiol. 2008, 51:750-7. 10.1016\/j.jacc.2007.10.041","journal-title":"J Am Coll Cardiol"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1067\/mtc.2001.114632","article-title":"Modified Glenn connection for acutely ischemic right ventricular failure reverses secondary left ventricular dysfunction","volume":"122","author":"Danton MH","year":"2001","unstructured":"Danton MH, Byrne JG, Flores KQ, et al.. Modified Glenn connection for acutely ischemic right ventricular failure reverses secondary left ventricular dysfunction. J Thorac Cardiovasc Surg. 2001, 122:80-91. 10.1067\/mtc.2001.114632","journal-title":"J Thorac Cardiovasc Surg"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1002\/ar.20798","article-title":"The three-dimensional arrangement of the myocytes aggregated together within the mammalian ventricular myocardium","volume":"292","author":"Smerup M","year":"2009","unstructured":"Smerup M, Nielsen E, Agger P, et al.. The three-dimensional arrangement of the myocytes aggregated together within the mammalian ventricular myocardium. Anat Rec (Hoboken). 2009, 292:1-11. 10.1002\/ar.20798","journal-title":"Anat Rec (Hoboken)"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.81.2.182","article-title":"Myoarchitecture and connective tissue in hearts with tricuspid atresia","volume":"81","author":"Sanchez-Quintana D","year":"1999","unstructured":"Sanchez-Quintana D, Climent V, Ho SY, Anderson RH. Myoarchitecture and connective tissue in hearts with tricuspid atresia. Heart. 1999, 81:182-91. 10.1136\/hrt.81.2.182","journal-title":"Heart"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccl.2017.07.006","article-title":"Cardiac tamponade","volume":"35","author":"Appleton C","year":"2017","unstructured":"Appleton C, Gillam L, Koulogiannis K. Cardiac tamponade. Cardiol Clin. 2017, 35:525-37. 10.1016\/j.ccl.2017.07.006","journal-title":"Cardiol Clin"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2017.11.003","article-title":"Tamponade: hemodynamic and echocardiographic diagnosis","volume":"153","author":"Kearns MJ","year":"2018","unstructured":"Kearns MJ, Walley KR. Tamponade: hemodynamic and echocardiographic diagnosis. Chest. 2018, 153:1266-75. 10.1016\/j.chest.2017.11.003","journal-title":"Chest"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2012.09.128","article-title":"Long-term survival after hospitalization for acute heart failure--differences in prognosis of acutely decompensated chronic and new-onset acute heart failure","volume":"168","author":"Lassus JP","year":"2013","unstructured":"Lassus JP, Siiril\u00e4-Waris K, Nieminen MS, et al.. Long-term survival after hospitalization for acute heart failure--differences in prognosis of acutely decompensated chronic and new-onset acute heart failure. Int J Cardiol. 2013, 168:458-62. 10.1016\/j.ijcard.2012.09.128","journal-title":"Int J Cardiol"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1007\/s10741-019-09894-y","article-title":"Acutely decompensated versus acute heart failure: two different entities","volume":"25","author":"Xanthopoulos A","year":"2020","unstructured":"Xanthopoulos A, Butler J, Parissis J, Polyzogopoulou E, Skoularigis J, Triposkiadis F. Acutely decompensated versus acute heart failure: two different entities. Heart Fail Rev. 2020, 25:907-16. 10.1007\/s10741-019-09894-y","journal-title":"Heart Fail Rev"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2019.05.031","article-title":"Differences in mortality of new-onset (de-novo) acute heart failure versus acute decompensated chronic heart failure","volume":"124","author":"Younis A","year":"2019","unstructured":"Younis A, Mulla W, Goldkorn R, et al.. Differences in mortality of new-onset (de-novo) acute heart failure versus acute decompensated chronic heart failure. Am J Cardiol. 2019, 124:554-9. 10.1016\/j.amjcard.2019.05.031","journal-title":"Am J Cardiol"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1007\/s11897-017-0351-y","article-title":"Acute heart failure: definition, classification and epidemiology","volume":"14","author":"Kurmani S","year":"2017","unstructured":"Kurmani S, Squire I. Acute heart failure: definition, classification and epidemiology. Curr Heart Fail Rep. 2017, 14:385-92. 10.1007\/s11897-017-0351-y","journal-title":"Curr Heart Fail Rep"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.119.011991","article-title":"Cardiogenic shock","volume":"8","author":"Vahdatpour C","year":"2019","unstructured":"Vahdatpour C, Collins D, Goldberg S. Cardiogenic shock. J Am Heart Assoc. 2019, 8:e011991. 10.1161\/JAHA.119.011991","journal-title":"J Am Heart Assoc"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199908263410901","article-title":"Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should we emergently revascularize occluded coronaries for cardiogenic shock","volume":"341","author":"Hochman JS","year":"1999","unstructured":"Hochman JS, Sleeper LA, Webb JG, et al.. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should we emergently revascularize occluded coronaries for cardiogenic shock. N Engl J Med. 1999, 341:625-34. 10.1056\/NEJM199908263410901","journal-title":"N Engl J Med"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1208410","article-title":"Intraaortic balloon support for myocardial infarction with cardiogenic shock","volume":"367","author":"Thiele H","year":"2012","unstructured":"Thiele H, Zeymer U, Neumann FJ, et al.. Intraaortic balloon support for myocardial infarction with cardiogenic shock. N Engl J Med. 2012, 367:1287-96. 10.1056\/NEJMoa1208410","journal-title":"N Engl J Med"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2011.11.020","article-title":"Use and outcomes of multivessel percutaneous coronary intervention in patients with acute myocardial infarction complicated by cardiogenic shock (from the EHS-PCI Registry)","volume":"109","author":"Bauer T","year":"2012","unstructured":"Bauer T, Zeymer U, Hochadel M, et al.. Use and outcomes of multivessel percutaneous coronary intervention in patients with acute myocardial infarction complicated by cardiogenic shock (from the EHS-PCI Registry). Am J Cardiol. 2012, 109:941-6. 10.1016\/j.amjcard.2011.11.020","journal-title":"Am J Cardiol"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehw128","article-title":"2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) developed with the special contribution of the Heart Failure Association (HFA) of the ESC","volume":"37","author":"Ponikowski P","year":"2016","unstructured":"Ponikowski P, Voors AA, Anker SD, et al.. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016, 37:2129-200. 10.1093\/eurheartj\/ehw128","journal-title":"Eur Heart J"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2017.12.028","article-title":"Multivessel percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction with cardiogenic shock","volume":"71","author":"Lee JM","year":"2018","unstructured":"Lee JM, Rhee TM, Hahn JY, et al.. Multivessel percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction with cardiogenic shock. J Am Coll Cardiol. 2018, 71:844-56. 10.1016\/j.jacc.2017.12.028","journal-title":"J Am Coll Cardiol"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1001\/jama.297.15.joc70035","article-title":"Effect of tilarginine acetate in patients with acute myocardial infarction and cardiogenic shock: the TRIUMPH randomized controlled trial","volume":"297","author":"Alexander JH","year":"2007","unstructured":"Alexander JH, Reynolds HR, Stebbins AL, Dzavik V, Harrington RA, Van de Werf F, Hochman JS. Effect of tilarginine acetate in patients with acute myocardial infarction and cardiogenic shock: the TRIUMPH randomized controlled trial. JAMA. 2007, 297:1657-66. 10.1001\/jama.297.15.joc70035","journal-title":"JAMA"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1710261","article-title":"PCI strategies in patients with acute myocardial infarction and cardiogenic shock","volume":"377","author":"Thiele H","year":"2017","unstructured":"Thiele H, Akin I, Sandri M, et al.. PCI strategies in patients with acute myocardial infarction and cardiogenic shock. N Engl J Med. 2017, 377:2419-32. 10.1056\/NEJMoa1710261","journal-title":"N Engl J Med"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.1492","article-title":"Acute heart failure congestion and perfusion status\u00a0-\u00a0impact of the clinical classification on in-hospital and long-term outcomes; insights from the ESC-EORP-HFA Heart Failure Long-Term Registry","volume":"21","author":"Chioncel O","year":"2019","unstructured":"Chioncel O, Mebazaa A, Maggioni AP, et al.. Acute heart failure congestion and perfusion status\u00a0-\u00a0impact of the clinical classification on in-hospital and long-term outcomes; insights from the ESC-EORP-HFA Heart Failure Long-Term Registry. Eur J Heart Fail. 2019, 21:1338-52. 10.1002\/ejhf.1492","journal-title":"Eur J Heart Fail"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.1502","article-title":"Clinical phenotypes of acute heart failure based on signs and symptoms of perfusion and congestion at emergency department presentation and their relationship with patient management and outcomes","volume":"21","author":"Javaloyes P","year":"2019","unstructured":"Javaloyes P, Mir\u00f3 \u00d2, Gil V, et al.. Clinical phenotypes of acute heart failure based on signs and symptoms of perfusion and congestion at emergency department presentation and their relationship with patient management and outcomes. Eur J Heart Fail. 2019, 21:1353-65. 10.1002\/ejhf.1502","journal-title":"Eur J Heart Fail"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1007\/s00392-018-1261-z","article-title":"Time trends in characteristics, clinical course, and outcomes of 13,791 patients with acute heart failure","volume":"107","author":"Llorens P","year":"2018","unstructured":"Llorens P, Javaloyes P, Mart\u00edn-S\u00e1nchez FJ, et al.. Time trends in characteristics, clinical course, and outcomes of 13,791 patients with acute heart failure. Clin Res Cardiol. 2018, 107:897-913. 10.1007\/s00392-018-1261-z","journal-title":"Clin Res Cardiol"},{"key":"ref63","doi-asserted-by":"crossref","DOI":"10.1016\/S0735-1097(00)00874-3","article-title":"The clinical profile of patients with suspected cardiogenic shock due to predominant left ventricular failure: a report from the SHOCK Trial Registry. Should we emergently revascularize occluded coronaries in cardiogenic shock?","volume":"36","author":"Menon V","year":"2000","unstructured":"Menon V, White H, LeJemtel T, Webb JG, Sleeper LA, Hochman JS. The clinical profile of patients with suspected cardiogenic shock due to predominant left ventricular failure: a report from the SHOCK Trial Registry. Should we emergently revascularize occluded coronaries in cardiogenic shock?. J Am Coll Cardiol. 2000, 36:1071-6.","journal-title":"J Am Coll Cardiol"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0b013e31828a67b2","article-title":"The systemic inflammatory response syndrome in patients with ST-segment elevation myocardial infarction","volume":"41","author":"van Diepen S","year":"2013","unstructured":"van Diepen S, Vavalle JP, Newby LK, et al.. The systemic inflammatory response syndrome in patients with ST-segment elevation myocardial infarction. Crit Care Med. 2013, 41:2080-7. 10.1097\/CCM.0b013e31828a67b2","journal-title":"Crit Care Med"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.106.613596","article-title":"Cardiogenic shock: current concepts and improving outcomes","volume":"117","author":"Reynolds HR","year":"2008","unstructured":"Reynolds HR, Hochman JS. Cardiogenic shock: current concepts and improving outcomes. Circulation. 2008, 117:686-97. 10.1161\/CIRCULATIONAHA.106.613596","journal-title":"Circulation"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1080\/17482940902807286","article-title":"Hemodynamic effects of levosimendan in acute myocardial infarction complicated by cardiogenic shock and high systemic vascular resistance","volume":"11","author":"Tsagalou EP","year":"2009","unstructured":"Tsagalou EP, Kanakakis J, Anastasiou-Nana MI, et al.. Hemodynamic effects of levosimendan in acute myocardial infarction complicated by cardiogenic shock and high systemic vascular resistance. Acute Card Care. 2009, 11:99-106. 10.1080\/17482940902807286","journal-title":"Acute Card Care"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.119.043080","article-title":"Value of hemodynamic monitoring in patients with cardiogenic shock undergoing mechanical circulatory support","volume":"141","author":"Saxena A","year":"2020","unstructured":"Saxena A, Garan AR, Kapur NK, et al.. Value of hemodynamic monitoring in patients with cardiogenic shock undergoing mechanical circulatory support. Circulation. 2020, 141:1184-97. 10.1161\/CIRCULATIONAHA.119.043080","journal-title":"Circulation"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.17925\/HI.2022.16.1.37","article-title":"A comprehensive review of mechanical circulatory support devices","volume":"16","author":"Atti V","year":"2022","unstructured":"Atti V, Narayanan MA, Patel B, Balla S, Siddique A, Lundgren S, Velagapudi P. A comprehensive review of mechanical circulatory support devices. Heart Int. 2022, 16:37-48. 10.17925\/HI.2022.16.1.37","journal-title":"Heart Int"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.4244\/EIJ-D-20-01296","article-title":"Management of cardiogenic shock","volume":"17","author":"Thiele H","year":"2021","unstructured":"Thiele H, de Waha-Thiele S, Freund A, Zeymer U, Desch S, Fitzgerald S. Management of cardiogenic shock. EuroIntervention. 2021, 17:451-65. 10.4244\/EIJ-D-20-01296","journal-title":"EuroIntervention"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2016.10.022","article-title":"Percutaneous mechanical circulatory support versus intra-aortic balloon pump\u00a0in cardiogenic shock after acute\u00a0myocardial infarction","volume":"69","author":"Ouweneel DM","year":"2017","unstructured":"Ouweneel DM, Eriksen E, Sjauw KD, et al.. Percutaneous mechanical circulatory support versus intra-aortic balloon pump\u00a0in cardiogenic shock after acute\u00a0myocardial infarction. J Am Coll Cardiol. 2017, 69:278-87. 10.1016\/j.jacc.2016.10.022","journal-title":"J Am Coll Cardiol"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2021.01.009","article-title":"Mortality in patients with cardiogenic shock supported with VA ECMO: a systematic review and meta-analysis evaluating the impact of etiology on 29,289 patients","volume":"40","author":"Alba AC","year":"2021","unstructured":"Alba AC, Foroutan F, Buchan TA, et al.. Mortality in patients with cardiogenic shock supported with VA ECMO: a systematic review and meta-analysis evaluating the impact of etiology on 29,289 patients. J Heart Lung Transplant. 2021, 40:260-8. 10.1016\/j.healun.2021.01.009","journal-title":"J Heart Lung Transplant"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.14797\/mdcj-16-1-7","article-title":"Pathophysiology and advanced hemodynamic assessment of cardiogenic shock","volume":"16","author":"Brener MI","year":"2020","unstructured":"Brener MI, Rosenblum HR, Burkhoff D. Pathophysiology and advanced hemodynamic assessment of cardiogenic shock. Methodist Debakey Cardiovasc J. 2020, 16:7-15. 10.14797\/mdcj-16-1-7","journal-title":"Methodist Debakey Cardiovasc J"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2015.10.017","article-title":"Hemodynamics of mechanical circulatory support","volume":"66","author":"Burkhoff D","year":"2015","unstructured":"Burkhoff D, Sayer G, Doshi D, Uriel N. Hemodynamics of mechanical circulatory support. J Am Coll Cardiol. 2015, 66:2663-74. 10.1016\/j.jacc.2015.10.017","journal-title":"J Am Coll Cardiol"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.1002\/ccd.25719","article-title":"2015 SCAI\/ACC\/HFSA\/STS clinical expert consensus statement on the use of percutaneous mechanical circulatory support devices in cardiovascular care (endorsed by the American Heart Association, the Cardiological Society of India, and Sociedad Latino Americana de Cardiolog\u00eda Intervencionista; affirmation of value by the Canadian Association of Interventional Cardiology-Association Canadienne de Cardiologie d'intervention)","volume":"85","author":"Rihal CS","year":"2015","unstructured":"Rihal CS, Naidu SS, Givertz MM, et al.. 2015 SCAI\/ACC\/HFSA\/STS clinical expert consensus statement on the use of percutaneous mechanical circulatory support devices in cardiovascular care (endorsed by the American Heart Association, the Cardiological Society of India, and Sociedad Latino Americana de Cardiolog\u00eda Intervencionista; affirmation of value by the Canadian Association of Interventional Cardiology-Association Canadienne de Cardiologie d'intervention). Catheter Cardiovasc Interv. 2015, 85:1112-4. 10.1002\/ccd.25719","journal-title":"Catheter Cardiovasc Interv"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2013.05.049","article-title":"Pressure-volume loops in clinical research: a contemporary view","volume":"62","author":"Burkhoff D","year":"2013","unstructured":"Burkhoff D. Pressure-volume loops in clinical research: a contemporary view. J Am Coll Cardiol. 2013, 62:1173-6. 10.1016\/j.jacc.2013.05.049","journal-title":"J Am Coll Cardiol"},{"key":"ref76","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2015.03.036","article-title":"2015 SCAI\/ACC\/HFSA\/STS clinical expert consensus statement on the use of percutaneous mechanical circulatory support devices in cardiovascular care: endorsed by the American Heart Assocation, the Cardiological Society of India, and Sociedad Latino Americana de Cardiologia Intervencion; affirmation of value by the Canadian Association of Interventional Cardiology-Association Canadienne de Cardiologie d'intervention","volume":"65","author":"Rihal CS","year":"2015","unstructured":"Rihal CS, Naidu SS, Givertz MM, et al.. 2015 SCAI\/ACC\/HFSA\/STS clinical expert consensus statement on the use of percutaneous mechanical circulatory support devices in cardiovascular care: endorsed by the American Heart Assocation, the Cardiological Society of India, and Sociedad Latino Americana de Cardiologia Intervencion; affirmation of value by the Canadian Association of Interventional Cardiology-Association Canadienne de Cardiologie d'intervention. J Am Coll Cardiol. 2015, 65:e7-e26. 10.1016\/j.jacc.2015.03.036","journal-title":"J Am Coll Cardiol"},{"key":"ref77","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.113.000285","article-title":"The myocardial oxygen supply: demand index revisited","volume":"3","author":"Hoffman JI","year":"2014","unstructured":"Hoffman JI, Buckberg GD. The myocardial oxygen supply: demand index revisited. J Am Heart Assoc. 2014, 3:e000285. 10.1161\/JAHA.113.000285","journal-title":"J Am Heart Assoc"},{"key":"ref78","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000075927.67673.F2","article-title":"Cardiogenic shock complicating acute myocardial infarction: expanding the paradigm","volume":"107","author":"Hochman JS","year":"2003","unstructured":"Hochman JS. Cardiogenic shock complicating acute myocardial infarction: expanding the paradigm. Circulation. 2003, 107:2998-3002. 10.1161\/01.CIR.0000075927.67673.F2","journal-title":"Circulation"},{"key":"ref79","doi-asserted-by":"publisher","DOI":"10.1007\/s00392-011-0403-3","article-title":"Interleukin-6, -7, -8 and -10 predict outcome in acute myocardial infarction complicated by cardiogenic shock","volume":"101","author":"Prondzinsky R","year":"2012","unstructured":"Prondzinsky R, Unverzagt S, Lemm H, et al.. Interleukin-6, -7, -8 and -10 predict outcome in acute myocardial infarction complicated by cardiogenic shock. Clin Res Cardiol. 2012, 101:375-84. 10.1007\/s00392-011-0403-3","journal-title":"Clin Res Cardiol"},{"key":"ref80","doi-asserted-by":"publisher","DOI":"10.1016\/j.hfc.2020.02.002","article-title":"Cardiac mechanoenergetics in patients with acute myocardial infarction: from pressure-volume loop diagram related to cardiac oxygen consumption","volume":"16","author":"Hieda M","year":"2020","unstructured":"Hieda M, Goto Y. Cardiac mechanoenergetics in patients with acute myocardial infarction: from pressure-volume loop diagram related to cardiac oxygen consumption. Heart Fail Clin. 2020, 16:255-69. 10.1016\/j.hfc.2020.02.002","journal-title":"Heart Fail Clin"},{"key":"ref81","doi-asserted-by":"publisher","DOI":"10.1007\/s10237-023-01734-1","article-title":"Post-infarct evolution of ventricular and myocardial function","volume":"22","author":"Janssens KL","year":"2023","unstructured":"Janssens KL, Kraamer M, Barbarotta L, Bovendeerd PH. Post-infarct evolution of ventricular and myocardial function. Biomech Model Mechanobiol. 2023, 22:1815-28. 10.1007\/s10237-023-01734-1","journal-title":"Biomech Model Mechanobiol"},{"key":"ref82","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.118.313650","article-title":"Medical therapy for heart failure associated with pulmonary hypertension","volume":"124","author":"Zelt JG","year":"2019","unstructured":"Zelt JG, Chaudhary KR, Cadete VJ, Mielniczuk LM, Stewart DJ. Medical therapy for heart failure associated with pulmonary hypertension. Circ Res. 2019, 124:1551-67. 10.1161\/CIRCRESAHA.118.313650","journal-title":"Circ Res"},{"key":"ref83","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2016.10.047","article-title":"The relationship between the right\u00a0ventricle and its load in pulmonary\u00a0hypertension","volume":"69","author":"Vonk Noordegraaf A","year":"2017","unstructured":"Vonk Noordegraaf A, Westerhof BE, Westerhof N. The relationship between the right\u00a0ventricle and its load in pulmonary\u00a0hypertension. J Am Coll Cardiol. 2017, 69:236-43. 10.1016\/j.jacc.2016.10.047","journal-title":"J Am Coll Cardiol"},{"key":"ref84","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2022.12.007","article-title":"Cardiogenic shock classification and associated mortality risk","volume":"98","author":"Hill KL","year":"2023","unstructured":"Hill KL, Rustin MA, Asche MA, Bennett CE, Patel PC, Jentzer JC. Cardiogenic shock classification and associated mortality risk. Mayo Clin Proc. 2023, 98:771-83. 10.1016\/j.mayocp.2022.12.007","journal-title":"Mayo Clin Proc"},{"key":"ref85","doi-asserted-by":"publisher","DOI":"10.1016\/j.bja.2021.06.048","article-title":"Heterogeneous impact of hypotension on organ perfusion and outcomes: a narrative review","volume":"127","author":"Meng L","year":"2021","unstructured":"Meng L. Heterogeneous impact of hypotension on organ perfusion and outcomes: a narrative review. Br J Anaesth. 2021, 127:845-61. 10.1016\/j.bja.2021.06.048","journal-title":"Br J Anaesth"},{"key":"ref86","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchf.2022.10.002","article-title":"Clinical presentation and in-hospital trajectory of heart\u00a0failure and cardiogenic\u00a0shock","volume":"11","author":"Hernandez-Montfort J","year":"2023","unstructured":"Hernandez-Montfort J, Kanwar M, Sinha SS, et al.. Clinical presentation and in-hospital trajectory of heart\u00a0failure and cardiogenic\u00a0shock. JACC Heart Fail. 2023, 11:176-87. 10.1016\/j.jchf.2022.10.002","journal-title":"JACC Heart Fail"},{"key":"ref87","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.120.007099","article-title":"Invasive hemodynamic assessment and classification of in-hospital mortality risk among patients with cardiogenic shock","volume":"13","author":"Thayer KL","year":"2020","unstructured":"Thayer KL, Zweck E, Ayouty M, et al.. Invasive hemodynamic assessment and classification of in-hospital mortality risk among patients with cardiogenic shock. Circ Heart Fail. 2020, 13:e007099. 10.1161\/CIRCHEARTFAILURE.120.007099","journal-title":"Circ Heart Fail"},{"key":"ref88","doi-asserted-by":"publisher","DOI":"10.1002\/ccd.28329","article-title":"SCAI clinical expert consensus statement on the classification of cardiogenic shock: this document was endorsed by the American College of Cardiology (ACC), the American Heart Association (AHA), the Society of Critical Care Medicine (SCCM), and the Society of Thoracic Surgeons (STS) in April 2019","volume":"94","author":"Baran DA","year":"2019","unstructured":"Baran DA, Grines CL, Bailey S, et al.. SCAI clinical expert consensus statement on the classification of cardiogenic shock: this document was endorsed by the American College of Cardiology (ACC), the American Heart Association (AHA), the Society of Critical Care Medicine (SCCM), and the Society of Thoracic Surgeons (STS) in April 2019. Catheter Cardiovasc Interv. 2019, 94:29-37. 10.1002\/ccd.28329","journal-title":"Catheter Cardiovasc Interv"},{"key":"ref89","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2022.01.018","article-title":"SCAI SHOCK stage classification expert consensus update: a review and incorporation of validation studies: this statement was endorsed by the American College of Cardiology (ACC), American College of Emergency Physicians (ACEP), American Heart Association (AHA), European Society of Cardiology (ESC) Association for Acute Cardiovascular Care (ACVC), International Society for Heart and Lung Transplantation (ISHLT), Society of Critical Care Medicine (SCCM), and Society of Thoracic Surgeons (STS) in December\u00a02021","volume":"79","author":"Naidu SS","year":"2022","unstructured":"Naidu SS, Baran DA, Jentzer JC, et al.. SCAI SHOCK stage classification expert consensus update: a review and incorporation of validation studies: this statement was endorsed by the American College of Cardiology (ACC), American College of Emergency Physicians (ACEP), American Heart Association (AHA), European Society of Cardiology (ESC) Association for Acute Cardiovascular Care (ACVC), International Society for Heart and Lung Transplantation (ISHLT), Society of Critical Care Medicine (SCCM), and Society of Thoracic Surgeons (STS) in December\u00a02021. J Am Coll Cardiol. 2022, 79:933-46. 10.1016\/j.jacc.2022.01.018","journal-title":"J Am Coll Cardiol"},{"key":"ref90","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0b013e31826e1058","article-title":"Third universal definition of myocardial infarction","volume":"126","author":"Thygesen K","year":"2012","unstructured":"Thygesen K, Alpert JS, Jaffe AS, et al.. Third universal definition of myocardial infarction. Circulation. 2012, 126:2020-35. 10.1161\/CIR.0b013e31826e1058","journal-title":"Circulation"},{"key":"ref91","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchf.2013.03.002","article-title":"Serum biomarkers in severe refractory cardiogenic shock","volume":"1","author":"Shah NR","year":"2013","unstructured":"Shah NR, Bieniarz MC, Basra SS, et al.. Serum biomarkers in severe refractory cardiogenic shock. JACC Heart Fail. 2013, 1:200-6. 10.1016\/j.jchf.2013.03.002","journal-title":"JACC Heart Fail"},{"key":"ref92","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2006.01.024","article-title":"Predictors of in-hospital mortality after percutaneous coronary intervention for cardiogenic shock","volume":"114","author":"Valente S","year":"2007","unstructured":"Valente S, Lazzeri C, Vecchio S, et al.. Predictors of in-hospital mortality after percutaneous coronary intervention for cardiogenic shock. Int J Cardiol. 2007, 114:176-82. 10.1016\/j.ijcard.2006.01.024","journal-title":"Int J Cardiol"},{"key":"ref93","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2015.04.242","article-title":"Prognostic impact of established and novel renal function biomarkers in myocardial infarction with cardiogenic shock: a biomarker substudy of the IABP-SHOCK II-trial","volume":"191","author":"Fuernau G","year":"2015","unstructured":"Fuernau G, Poenisch C, Eitel I, et al.. Prognostic impact of established and novel renal function biomarkers in myocardial infarction with cardiogenic shock: a biomarker substudy of the IABP-SHOCK II-trial. Int J Cardiol. 2015, 191:159-66. 10.1016\/j.ijcard.2015.04.242","journal-title":"Int J Cardiol"},{"key":"ref94","doi-asserted-by":"publisher","DOI":"10.1016\/j.rec.2016.11.029","article-title":"Left ventricular ejection fraction in patients with acute heart failure: a limited tool?","volume":"70","author":"Kalogeropoulos AP","year":"2017","unstructured":"Kalogeropoulos AP, Butler J. Left ventricular ejection fraction in patients with acute heart failure: a limited tool?. Rev Esp Cardiol (Engl Ed). 2017, 70:318-9. 10.1016\/j.rec.2016.11.029","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"key":"ref95","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.116.025795","article-title":"Ejection fraction: misunderstood and overrated (changing the paradigm in categorizing heart failure)","volume":"135","author":"Konstam MA","year":"2017","unstructured":"Konstam MA, Abboud FM. Ejection fraction: misunderstood and overrated (changing the paradigm in categorizing heart failure). Circulation. 2017, 135:717-9. 10.1161\/CIRCULATIONAHA.116.025795","journal-title":"Circulation"},{"key":"ref96","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehv510","article-title":"Beyond ejection fraction: an integrative approach for assessment of cardiac structure and function in heart failure","volume":"37","author":"Cikes M","year":"2016","unstructured":"Cikes M, Solomon SD. Beyond ejection fraction: an integrative approach for assessment of cardiac structure and function in heart failure. Eur Heart J. 2016, 37:1642-50. 10.1093\/eurheartj\/ehv510","journal-title":"Eur Heart J"},{"key":"ref97","doi-asserted-by":"publisher","DOI":"10.1007\/s10741-019-09828-8","article-title":"Structural and myocardial dysfunction in heart failure beyond ejection fraction","volume":"25","author":"Severino P","year":"2020","unstructured":"Severino P, Maestrini V, Mariani MV, Birtolo LI, Scarpati R, Mancone M, Fedele F. Structural and myocardial dysfunction in heart failure beyond ejection fraction. Heart Fail Rev. 2020, 25:9-17. 10.1007\/s10741-019-09828-8","journal-title":"Heart Fail Rev"},{"key":"ref98","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2018.08.2162","article-title":"Ejection fraction pros and cons: JACC state-of-the-art review","volume":"72","author":"Marwick TH","year":"2018","unstructured":"Marwick TH. Ejection fraction pros and cons: JACC state-of-the-art review. J Am Coll Cardiol. 2018, 72:2360-79. 10.1016\/j.jacc.2018.08.2162","journal-title":"J Am Coll Cardiol"},{"key":"ref99","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2014-305538","article-title":"Prognostic implications of global LV dysfunction: a systematic review and meta-analysis of global longitudinal strain and ejection fraction","volume":"100","author":"Kalam K","year":"2014","unstructured":"Kalam K, Otahal P, Marwick TH. Prognostic implications of global LV dysfunction: a systematic review and meta-analysis of global longitudinal strain and ejection fraction. Heart. 2014, 100:1673-80. 10.1136\/heartjnl-2014-305538","journal-title":"Heart"},{"key":"ref100","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2014-306186","article-title":"Should LVEF be replaced by global longitudinal strain?","volume":"100","author":"Szymanski C","year":"2014","unstructured":"Szymanski C, L\u00e9vy F, Tribouilloy C. Should LVEF be replaced by global longitudinal strain?. Heart. 2014, 100:1655-6. 10.1136\/heartjnl-2014-306186","journal-title":"Heart"},{"key":"ref101","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2013.02.061","article-title":"Prediction of all-cause mortality and heart failure admissions from global left ventricular longitudinal strain in patients with acute myocardial infarction and preserved left ventricular ejection fraction","volume":"61","author":"Ersb\u00f8ll M","year":"2013","unstructured":"Ersb\u00f8ll M, Valeur N, Mogensen UM, et al.. Prediction of all-cause mortality and heart failure admissions from global left ventricular longitudinal strain in patients with acute myocardial infarction and preserved left ventricular ejection fraction. J Am Coll Cardiol. 2013, 61:2365-73. 10.1016\/j.jacc.2013.02.061","journal-title":"J Am Coll Cardiol"},{"key":"ref102","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmg.2015.07.013","article-title":"Global longitudinal strain is a superior predictor of all-cause mortality in heart failure with reduced ejection fraction","volume":"8","author":"Sengel\u00f8v M","year":"2015","unstructured":"Sengel\u00f8v M, J\u00f8rgensen PG, Jensen JS, et al.. Global longitudinal strain is a superior predictor of all-cause mortality in heart failure with reduced ejection fraction. JACC Cardiovasc Imaging. 2015, 8:1351-9. 10.1016\/j.jcmg.2015.07.013","journal-title":"JACC Cardiovasc Imaging"},{"key":"ref103","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.154","article-title":"Prevalence and prognostic value of subclinical left ventricular systolic dysfunction by global longitudinal strain in a community-based cohort","volume":"16","author":"Russo C","year":"2014","unstructured":"Russo C, Jin Z, Elkind MS, Rundek T, Homma S, Sacco RL, Di Tullio MR. Prevalence and prognostic value of subclinical left ventricular systolic dysfunction by global longitudinal strain in a community-based cohort. Eur J Heart Fail. 2014, 16:1301-9. 10.1002\/ejhf.154","journal-title":"Eur J Heart Fail"},{"key":"ref104","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmg.2017.11.017","article-title":"Assessment of left ventricular function by echocardiography: the case for routinely adding global longitudinal strain to ejection fraction","volume":"11","author":"Potter E","year":"2018","unstructured":"Potter E, Marwick TH. Assessment of left ventricular function by echocardiography: the case for routinely adding global longitudinal strain to ejection fraction. JACC Cardiovasc Imaging. 2018, 11:260-74. 10.1016\/j.jcmg.2017.11.017","journal-title":"JACC Cardiovasc Imaging"},{"key":"ref105","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.260","article-title":"Clinical picture and risk prediction of short-term mortality in cardiogenic shock","volume":"17","author":"Harjola VP","year":"2015","unstructured":"Harjola VP, Lassus J, Sionis A, et al.. Clinical picture and risk prediction of short-term mortality in cardiogenic shock. Eur J Heart Fail. 2015, 17:501-9. 10.1002\/ejhf.260","journal-title":"Eur J Heart Fail"},{"key":"ref106","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2017.02.027","article-title":"Risk stratification for patients in\u00a0cardiogenic shock after acute\u00a0myocardial\u00a0infarction","volume":"69","author":"P\u00f6ss J","year":"2017","unstructured":"P\u00f6ss J, K\u00f6ster J, Fuernau G, et al.. Risk stratification for patients in\u00a0cardiogenic shock after acute\u00a0myocardial\u00a0infarction. J Am Coll Cardiol. 2017, 69:1913-20. 10.1016\/j.jacc.2017.02.027","journal-title":"J Am Coll Cardiol"},{"key":"ref107","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehy127","article-title":"Predicting the development of in-hospital cardiogenic shock in patients with ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention: the ORBI risk score","volume":"39","author":"Auffret V","year":"2018","unstructured":"Auffret V, Cottin Y, Leurent G, et al.. Predicting the development of in-hospital cardiogenic shock in patients with ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention: the ORBI risk score. Eur Heart J. 2018, 39:2090-102. 10.1093\/eurheartj\/ehy127","journal-title":"Eur Heart J"},{"key":"ref108","doi-asserted-by":"publisher","DOI":"10.3390\/medicina60010183","article-title":"Differential prognostic impact of IABP-SHOCK II scores according to treatment strategy in cardiogenic shock complicating acute coronary syndrome: from the RESCUE registry","volume":"60","author":"Kim BS","year":"2024","unstructured":"Kim BS, Jang WJ, Choi KH, et al.. Differential prognostic impact of IABP-SHOCK II scores according to treatment strategy in cardiogenic shock complicating acute coronary syndrome: from the RESCUE registry. Medicina (Kaunas). 2024, 60:183. 10.3390\/medicina60010183","journal-title":"Medicina (Kaunas)"},{"key":"ref109","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2023.12.018","article-title":"Prognostic performance of the IABP-SHOCK II Risk Score among cardiogenic shock subtypes in the critical care cardiology trials network registry","volume":"270","author":"Alviar CL","year":"2024","unstructured":"Alviar CL, Li BK, Keller NM, et al.. Prognostic performance of the IABP-SHOCK II Risk Score among cardiogenic shock subtypes in the critical care cardiology trials network registry. Am Heart J. 2024, 270:1-12. 10.1016\/j.ahj.2023.12.018","journal-title":"Am Heart J"},{"key":"ref110","doi-asserted-by":"publisher","DOI":"10.1177\/2048872617706503","article-title":"Risk factors of late cardiogenic shock and mortality in ST-segment elevation myocardial infarction patients","volume":"7","author":"Obling L","year":"2018","unstructured":"Obling L, Frydland M, Hansen R, et al.. Risk factors of late cardiogenic shock and mortality in ST-segment elevation myocardial infarction patients. Eur Heart J Acute Cardiovasc Care. 2018, 7:7-15. 10.1177\/2048872617706503","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"ref111","doi-asserted-by":"publisher","DOI":"10.1016\/j.ehj.2003.12.008","article-title":"Predictors of in-hospital mortality in 1333 patients with acute myocardial infarction complicated by cardiogenic shock treated with primary percutaneous coronary intervention (PCI); results of the primary PCI registry of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhaus\u00e4rzte (ALKK)","volume":"25","author":"Zeymer U","year":"2004","unstructured":"Zeymer U, Vogt A, Zahn R, et al.. Predictors of in-hospital mortality in 1333 patients with acute myocardial infarction complicated by cardiogenic shock treated with primary percutaneous coronary intervention (PCI); results of the primary PCI registry of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhaus\u00e4rzte (ALKK). Eur Heart J. 2004, 25:322-8. 10.1016\/j.ehj.2003.12.008","journal-title":"Eur Heart J"},{"key":"ref112","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.2003.021691","article-title":"Predictors of outcome after percutaneous treatment for cardiogenic shock","volume":"91","author":"Sutton AG","year":"2005","unstructured":"Sutton AG, Finn P, Hall JA, Harcombe AA, Wright RA, de Belder MA. Predictors of outcome after percutaneous treatment for cardiogenic shock. Heart. 2005, 91:339-44. 10.1136\/hrt.2003.021691","journal-title":"Heart"},{"key":"ref113","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2005.02.040","article-title":"Mortality after emergent percutaneous coronary intervention in cardiogenic shock secondary to acute myocardial infarction and usefulness of a mortality prediction model","volume":"96","author":"Klein LW","year":"2005","unstructured":"Klein LW, Shaw RE, Krone RJ, et al.. Mortality after emergent percutaneous coronary intervention in cardiogenic shock secondary to acute myocardial infarction and usefulness of a mortality prediction model. Am J Cardiol. 2005, 96:35-41. 10.1016\/j.amjcard.2005.02.040","journal-title":"Am J Cardiol"},{"key":"ref114","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2009.08.005","article-title":"Predictors of 30-day mortality in patients with refractory cardiogenic shock following acute myocardial infarction despite a patent infarct artery","volume":"158","author":"Katz JN","year":"2009","unstructured":"Katz JN, Stebbins AL, Alexander JH, et al.. Predictors of 30-day mortality in patients with refractory cardiogenic shock following acute myocardial infarction despite a patent infarct artery. Am Heart J. 2009, 158:680-7. 10.1016\/j.ahj.2009.08.005","journal-title":"Am Heart J"},{"key":"ref115","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2010.06.024","article-title":"A severity scoring system for risk assessment of patients with cardiogenic shock: a report from the SHOCK Trial and Registry","volume":"160","author":"Sleeper LA","year":"2010","unstructured":"Sleeper LA, Reynolds HR, White HD, Webb JG, Dzav\u00edk V, Hochman JS. A severity scoring system for risk assessment of patients with cardiogenic shock: a report from the SHOCK Trial and Registry. Am Heart J. 2010, 160:443-50. 10.1016\/j.ahj.2010.06.024","journal-title":"Am Heart J"},{"key":"ref116","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehz363","article-title":"Management of cardiogenic shock complicating myocardial infarction: an update 2019","volume":"40","author":"Thiele H","year":"2019","unstructured":"Thiele H, Ohman EM, de Waha-Thiele S, Zeymer U, Desch S. Management of cardiogenic shock complicating myocardial infarction: an update 2019. Eur Heart J. 2019, 40:2671-83. 10.1093\/eurheartj\/ehz363","journal-title":"Eur Heart J"},{"key":"ref117","doi-asserted-by":"publisher","DOI":"10.1111\/aor.13099","article-title":"Heart transplantation in patients supported by ECMO: is the APACHE IV score a predictor of survival?","volume":"42","author":"Lechiancole A","year":"2018","unstructured":"Lechiancole A, Sponga S, Isola M, Vendramin I, Maiani M, Livi U. Heart transplantation in patients supported by ECMO: is the APACHE IV score a predictor of survival?. Artif Organs. 2018, 42:670-3. 10.1111\/aor.13099","journal-title":"Artif Organs"},{"key":"ref118","doi-asserted-by":"publisher","DOI":"10.1378\/chest.08-2591","article-title":"Mortality probability model III and simplified acute physiology score II: assessing their value in predicting length of stay and comparison to APACHE IV","volume":"136","author":"Vasilevskis EE","year":"2009","unstructured":"Vasilevskis EE, Kuzniewicz MW, Cason BA, et al.. Mortality probability model III and simplified acute physiology score II: assessing their value in predicting length of stay and comparison to APACHE IV. Chest. 2009, 136:89-101. 10.1378\/chest.08-2591","journal-title":"Chest"},{"key":"ref119","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrc.2016.01.013","article-title":"The predictive performance of the SAPS II and SAPS 3 scoring systems: a retrospective analysis","volume":"33","author":"Katsounas A","year":"2016","unstructured":"Katsounas A, Kamacharova I, Tyczynski B, et al.. The predictive performance of the SAPS II and SAPS 3 scoring systems: a retrospective analysis. J Crit Care. 2016, 33:180-5. 10.1016\/j.jcrc.2016.01.013","journal-title":"J Crit Care"},{"key":"ref120","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-019-2663-7","article-title":"The SOFA score-development, utility and challenges of accurate assessment in clinical trials","volume":"23","author":"Lambden S","year":"2019","unstructured":"Lambden S, Laterre PF, Levy MM, Francois B. The SOFA score-development, utility and challenges of accurate assessment in clinical trials. Crit Care. 2019, 23:374. 10.1186\/s13054-019-2663-7","journal-title":"Crit Care"},{"key":"ref121","doi-asserted-by":"publisher","DOI":"10.1007\/s00063-013-0234-2","article-title":"Predictive value of outcome scores in patients suffering from cardiogenic shock complicating AMI: APACHE II, APACHE III, Elebute-Stoner, SOFA, and SAPS II","volume":"108","author":"Kellner P","year":"2013","unstructured":"Kellner P, Prondzinsky R, Pallmann L, et al.. Predictive value of outcome scores in patients suffering from cardiogenic shock complicating AMI: APACHE II, APACHE III, Elebute-Stoner, SOFA, and SAPS II. Med Klin Intensivmed Notfmed. 2013, 108:666-74. 10.1007\/s00063-013-0234-2","journal-title":"Med Klin Intensivmed Notfmed"},{"key":"ref122","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.2449","article-title":"Early risk stratification in patients with cardiogenic shock irrespective of the underlying cause\u00a0-\u00a0the Cardiogenic Shock Score","volume":"24","author":"Beer BN","year":"2022","unstructured":"Beer BN, Jentzer JC, Weimann J, et al.. Early risk stratification in patients with cardiogenic shock irrespective of the underlying cause\u00a0-\u00a0the Cardiogenic Shock Score. Eur J Heart Fail. 2022, 24:657-67. 10.1002\/ejhf.2449","journal-title":"Eur J Heart Fail"},{"key":"ref123","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2011.11.010","article-title":"Post-myocardial infarction cardiogenic shock is a systemic illness in need of systemic treatment: is therapeutic hypothermia one possibility?","volume":"59","author":"Stegman BM","year":"2012","unstructured":"Stegman BM, Newby LK, Hochman JS, Ohman EM. Post-myocardial infarction cardiogenic shock is a systemic illness in need of systemic treatment: is therapeutic hypothermia one possibility?. J Am Coll Cardiol. 2012, 59:644-7. 10.1016\/j.jacc.2011.11.010","journal-title":"J Am Coll Cardiol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/305441-cardiac-failure-and-cardiogenic-shock-insights-into-pathophysiology-classification-and-hemodynamic-assessment","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,22]],"date-time":"2024-10-22T11:31:49Z","timestamp":1729596709000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/305441-cardiac-failure-and-cardiogenic-shock-insights-into-pathophysiology-classification-and-hemodynamic-assessment"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,22]]},"references-count":123,"URL":"https:\/\/doi.org\/10.7759\/cureus.72106","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10,22]]}}}